Company / Operating Income per Share
Charles River Laboratories Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$0.51
FY2025
5-year range
$0.51 / $11.58
FY2021-FY2025
Trend
-88.5%
vs FY2024
Sector context
#91 of 155
Health Care
What the data says
At $0.51, Charles River Laboratories's operating income per share ranks #91 of 155 in the Health Care sector. Operating Income per Share has fluctuated over the past 10 years, ranging from $0.51 in FY2025 to $11.58 in FY2023.
Based on SEC 10-K filings.
0.51 in FY2025 with a 5-year CAGR of -40.4%.
Declined from $11.58 to $0.51 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -60.9%
- 5-Year CAGR
- -40.4%
- 10-Year CAGR
- -
Sector benchmark
#91 of 155 in Health CareTop 59% of 155This company $0.51 Sector average $4.18
▼
-87.8% below sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 88.5% year-over-year.
- Ranks #91 out of 155 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.51 | -88.5% |
| FY2024 | $4.43 | -61.8% |
| FY2023 | $11.58 | +35.1% |
| FY2022 | $8.57 | +21.5% |
| FY2021 | $7.06 | +4.2% |
| FY2020 | $6.77 | +13.2% |
| FY2019 | $5.98 | -14.5% |
| FY2018 | $6.99 | +14.9% |
| FY2017 | $6.09 | +19.7% |
| FY2016 | $5.09 | +59.0% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026